Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- Check4 days agoChange DetectedThe page content regarding the study details appears unchanged, with only minor visual/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check33 days agoChange Detected- Added a government funding lapse notice and operating-status details (affecting transaction processing and inquiries). - Updated version to v3.2.0, removing the previous v3.1.0.SummaryDifference3%

- Check40 days agoChange DetectedVersion upgrade to v3.1.0 with removal of multiple drug-safety subtopics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a reorganization or narrowing of content.SummaryDifference0.4%

- Check54 days agoChange DetectedThe page version changed from v3.0.1 to v3.0.2, and the Back to Top link was removed. No substantive changes to core content, pricing, or availability are detected.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to drug safety and counterfeit drugs. Notably, references to specific diseases and previous MedlinePlus topics have been removed.SummaryDifference4%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.